BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 21055184)

  • 1. [Richter syndrome: report of a case].
    Chen DB; Song QJ; Shen DH
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):487-8. PubMed ID: 21055184
    [No Abstract]   [Full Text] [Related]  

  • 2. [CD5-positive cardiac intravascular diffuse large-B cell lymphoma: report of a case].
    He RQ; Chen G; Li ZY
    Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):835-6. PubMed ID: 24507104
    [No Abstract]   [Full Text] [Related]  

  • 3. [Primary diffuse large B-cell lymphoma in uterine corpus: report of a case].
    Dong W; Cao L; Wang DS
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):270-2. PubMed ID: 21616007
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diffuse large B-cell lymphoma following nodular lymphocyte predominant Hodgkin's lymphoma: report of a case].
    Chen DB; Wang Y; Shen DH
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):635-6. PubMed ID: 21092597
    [No Abstract]   [Full Text] [Related]  

  • 5. Follow-up data of 10 patients with B-cell non-Hodgkin lymphoma with a CD20-negative phenotypic change after rituximab-containing therapy.
    Maeshima AM; Taniguchi H; Fukuhara S; Morikawa N; Munakata W; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
    Am J Surg Pathol; 2013 Apr; 37(4):563-70. PubMed ID: 23426122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of ibrutinib in the treatment of Richter syndrome.
    Tsang M; Shanafelt TD; Call TG; Ding W; Chanan-Khan A; Leis JF; Nowakowski GS; Bowen D; Conte M; Schwager SM; Slager SL; Kay NE; Hanson CA; Parikh SA
    Blood; 2015 Mar; 125(10):1676-8. PubMed ID: 25745187
    [No Abstract]   [Full Text] [Related]  

  • 7. A blind skin biopsy diagnosing an intravascular large B-cell lymphoma.
    Deschamps L; Signate A; Delaunay C; Morales I; Warter A; Smadja D; Derancourt C
    Eur J Dermatol; 2011; 21(1):114-5. PubMed ID: 21233067
    [No Abstract]   [Full Text] [Related]  

  • 8. Rituximab and bendamustine in patients with CD20+ diffuse large B-cell lymphoma not eligible for cyclophosphamide, doxorubicin, vincristine and prednisone-like chemotherapy.
    Walter E; Schmitt T; Dietrich S; Ho A; Witzens-Harig M
    Leuk Lymphoma; 2012 Nov; 53(11):2290-2. PubMed ID: 22475324
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intravascular large B-cell lymphoma: report of a case].
    Yu GH; Qu GM; Yao WD; Lang ZQ; Wang W
    Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):488-9. PubMed ID: 19781202
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical manifestation of targeted drugs in individualized therapy of malignant tumors].
    Chu DT
    Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):721-4. PubMed ID: 21163058
    [No Abstract]   [Full Text] [Related]  

  • 11. Composite diffuse large B-cell lymphoma and CD20-positive peripheral T-cell lymphoma.
    Yamazaki S; Fujioka Y; Nakamura F; Ota S; Shinozaki A; Yamamoto G; Kamikubo Y; Nannya Y; Ichikawa M; Fukayama M; Kurokawa M
    Pathol Int; 2011 Nov; 61(11):662-6. PubMed ID: 22029677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased rituximab (R) doses eliminate increased risk and improve outcome of elderly male patients with aggressive CD20+ B-cell lymphomas: the SEXIE-R-CHOP-14 trial of the DSHNHL.
    Clin Adv Hematol Oncol; 2014 Aug; 12(8 Suppl 16):8-9. PubMed ID: 25768993
    [No Abstract]   [Full Text] [Related]  

  • 13. High-risk diffuse large B-cell lymphoma: can we do better than rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone?
    George A; Tam CS; Seymour JF
    Leuk Lymphoma; 2013 Dec; 54(12):2575-6. PubMed ID: 23597141
    [No Abstract]   [Full Text] [Related]  

  • 14. Conjunctival lymphoma in a child.
    Waisbourd M; Leibovitch I; Sayar D; Elhasid R
    Cornea; 2011 May; 30(5):598-9. PubMed ID: 21107252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [EBV-positive diffuse large B-cell lymphoma in young individual: report of a case].
    Li WS; Xie JL; Zhang M; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):128-9. PubMed ID: 23710923
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunochemotherapy is the standard of care in elderly patients with diffuse large B-cell lymphoma.
    Coiffier B; Salles G
    Blood; 2004 Sep; 104(5):1584-5; author reply 1585-6. PubMed ID: 15317734
    [No Abstract]   [Full Text] [Related]  

  • 17. A treatment for activated B-cell-like DLBCL?
    Zinzani PL
    Lancet Oncol; 2014 Aug; 15(9):916-7. PubMed ID: 25042201
    [No Abstract]   [Full Text] [Related]  

  • 18. [Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: clinicopathologic characterization of 16 cases showing different patterns].
    Wang L; Wang W; Li X; Guo Y; Zhu X
    Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):307-12. PubMed ID: 25030862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is radiotherapy still necessary for diffuse large B-cell lymphoma therapy?
    Mondello P; Cuzzocrea S; Pitini V; Aloisi C; Mian M
    Acta Oncol; 2015 Jun; 54(6):953-5. PubMed ID: 25831143
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-CD20 antibody therapy for B-cell lymphomas.
    Maloney DG
    N Engl J Med; 2012 May; 366(21):2008-16. PubMed ID: 22621628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.